Literature DB >> 4018882

Adjuvant activity of saponin: antigen localization studies.

M T Scott, M Goss-Sampson, R Bomford.   

Abstract

The adjuvant saponin potentiates the antibody response of mice to the antigen keyhole limpet hemocyanin (KLH). Studies using 125I-labelled KLH show that saponin significantly prolongs the retention of antigen at the subcutaneous injection site and also increases the amount reaching the spleen. Both these phenomena were associated with the inflammatory response to saponin and were markedly reduced following abolition of the inflammatory action of saponin by addition of cholesterol-containing liposomes. The adjuvant action of saponin was not modified by this treatment. Further evidence that neither antigen retention nor splenic localization is implicated in the adjuvant action of saponin for KLH is the demonstration that digitonin, which shares hemolytic and cholesterol binding activity with saponin, caused similar antigen retention and splenic localization but was not adjuvant active.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4018882     DOI: 10.1159/000233817

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  5 in total

1.  Inflammatory response and antigen localization following immunization with influenza virus ISCOMs.

Authors:  D L Watson; K Lövgren; N A Watson; C Fossum; B Morein; S Höglund
Journal:  Inflammation       Date:  1989-12       Impact factor: 4.092

2.  Immunogenicity of liposomes and iscoms containing the major outer membrane protein of Neisseria gonorrhoeae: influence of protein content and liposomal bilayer composition.

Authors:  G F Kersten; A M van de Put; T Teerlink; E C Beuvery; D J Crommelin
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

3.  A semisynthetic Quillaja saponin as a drug delivery agent for aminoglycoside antibiotics.

Authors:  J Recchia; M H Lurantos; J A Amsden; J Storey; C R Kensil
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

4.  Development of a minimal saponin vaccine adjuvant based on QS-21.

Authors:  Alberto Fernández-Tejada; Eric K Chea; Constantine George; NagaVaraKishore Pillarsetty; Jeffrey R Gardner; Philip O Livingston; Govind Ragupathi; Jason S Lewis; Derek S Tan; David Y Gin
Journal:  Nat Chem       Date:  2014-06-01       Impact factor: 24.427

5.  Development of Improved Vaccine Adjuvants Based on the Saponin Natural Product QS-21 through Chemical Synthesis.

Authors:  Alberto Fernández-Tejada; Derek S Tan; David Y Gin
Journal:  Acc Chem Res       Date:  2016-08-28       Impact factor: 22.384

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.